Pregnant women and neonates are often categorised as being at high risk during the
coronavirus disease-2019 (COVID-19) pandemic. Numerous studies have demonstrated …

Objective Few large cohort studies have reported data on maternal, fetal, perinatal and
neonatal outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS …

Objective To assess the frequency and associated characteristics of COVID‐19 vaccine
hesitancy among pregnant and postpartum individuals. Design Cross‐sectional study …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(coronavirus disease 2019,
COVID-19) is a pandemic disease with rapidly and widely disseminating to the world. Based …

BNT162b2 is a vaccine developed to prevent coronavirus disease 2019 (COVID-19).
BNT162b2 is a lipid nanoparticle formulated nucleoside-modified messenger RNA (mRNA) …

Abstract Nirmatrelvir (PF-07321332; NMV) the antiviral component of PAXLOVID™ is a
potent and selective inhibitor of the SARS-CoV-2 main protease (M pro), which plays a …

Objective To assess perinatal outcomes for pregnancies affected by suspected or confirmed
SARS-CoV-2 infection. Methods Prospective, web-based registry. Pregnant women were …

During the global COVID-19 pandemic, data from clinical studies, systematic review, and
population registry data have shown that when compared with non-pregnant women, SARS …

Although risk of vertical or perinatal transmission is low across a range of postnatal care
practices, early indicators suggest developmental risk to the generation born during the …

In May 2020, a pregnant woman in her 37th pregnancy week was diagnosed with COVID-19
in St. Petersburg in Russia. All treatments failed and the patient died after 11 days due to …